BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30603478)

  • 1. Local Delivery of CTGF siRNA with Poly(sorbitol-co-PEI) Reduces Scar Contraction in Cutaneous Wound Healing.
    Cho KH; Singh B; Maharjan S; Jang Y; Choi YJ; Cho CS
    Tissue Eng Regen Med; 2017 Jun; 14(3):211-220. PubMed ID: 30603478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanolayered siRNA delivery platforms for local silencing of CTGF reduce cutaneous scar contraction in third-degree burns.
    Castleberry SA; Golberg A; Sharkh MA; Khan S; Almquist BD; Austen WG; Yarmush ML; Hammond PT
    Biomaterials; 2016 Jul; 95():22-34. PubMed ID: 27108403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of hydrocinnamoyl-L-valyl pyrrolidine on healing quality of deep partial-thickness scald wound in mice].
    Yang ML; Li YH; Tan Q; Li JT; Que LL
    Zhonghua Shao Shang Za Zhi; 2016 Nov; 32(11):658-666. PubMed ID: 27894387
    [No Abstract]   [Full Text] [Related]  

  • 4. Local Silencing of Connective Tissue Growth Factor by siRNA/Peptide Improves Dermal Collagen Arrangements.
    Cho Lee AR; Woo I
    Tissue Eng Regen Med; 2018 Dec; 15(6):711-719. PubMed ID: 30603590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Adenovirus-Mediated Down-Regulation of Connective Tissue Growth Factor on Postoperative Wound Healing After Experimental Glaucoma Surgery.
    Lim DH; Kim TE; Kee C
    Curr Eye Res; 2016 Jul; 41(7):951-6. PubMed ID: 26554857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M2-polarized macrophages mediate wound healing by regulating connective tissue growth factor via AKT, ERK1/2, and STAT3 signaling pathways.
    Zhang SM; Wei CY; Wang Q; Wang L; Lu L; Qi FZ
    Mol Biol Rep; 2021 Sep; 48(9):6443-6456. PubMed ID: 34398425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connective tissue growth factor siRNA modulates mRNA levels for a subset of molecules in normal and TGF-beta 1-stimulated porcine skin fibroblasts.
    Wang JF; Olson ME; Ma L; Brigstock DR; Hart DA
    Wound Repair Regen; 2004; 12(2):205-16. PubMed ID: 15086772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention.
    Ferguson MW; O'Kane S
    Philos Trans R Soc Lond B Biol Sci; 2004 May; 359(1445):839-50. PubMed ID: 15293811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of tumor growth in lung cancer xenograft model mice by poly(sorbitol-co-PEI)-mediated delivery of osteopontin siRNA.
    Cho WY; Hong SH; Singh B; Islam MA; Lee S; Lee AY; Gankhuyag N; Kim JE; Yu KN; Kim KH; Park YC; Cho CS; Cho MH
    Eur J Pharm Biopharm; 2015 Aug; 94():450-62. PubMed ID: 26141346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of JNK signaling mediates connective tissue growth factor expression and scar formation in corneal wound healing.
    Shi L; Chang Y; Yang Y; Zhang Y; Yu FS; Wu X
    PLoS One; 2012; 7(2):e32128. PubMed ID: 22363806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of connective tissue growth factor, transforming growth factor and Smad signaling pathway during corneal wound healing].
    Yang YM; Wu XY; Du LQ
    Zhonghua Yan Ke Za Zhi; 2006 Oct; 42(10):918-24. PubMed ID: 17217787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. siRNA-targeting transforming growth factor-β type I receptor reduces wound scarring and extracellular matrix deposition of scar tissue.
    Wang YW; Liou NH; Cherng JH; Chang SJ; Ma KH; Fu E; Liu JC; Dai NT
    J Invest Dermatol; 2014 Jul; 134(7):2016-2025. PubMed ID: 24670383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense inhibition of connective tissue growth factor (CTGF/CCN2) mRNA limits hypertrophic scarring without affecting wound healing in vivo.
    Sisco M; Kryger ZB; O'Shaughnessy KD; Kim PS; Schultz GS; Ding XZ; Roy NK; Dean NM; Mustoe TA
    Wound Repair Regen; 2008; 16(5):661-73. PubMed ID: 19128261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNAi nanotherapy for fibrosis: highly durable knockdown of CTGF/CCN-2 using siRNA-DegradaBALL (LEM-S401) to treat skin fibrotic diseases.
    Kang S; Kim J; Ahn M; Kim J; Heo MG; Min DH; Won C
    Nanoscale; 2020 Mar; 12(11):6385-6393. PubMed ID: 32134425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimum scratch assay condition to evaluate connective tissue growth factor expression for anti-scar therapy.
    Moon H; Yong H; Lee AR
    Arch Pharm Res; 2012 Feb; 35(2):383-8. PubMed ID: 22370794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acellular dermal matrix scaffolds coated with connective tissue growth factor accelerate diabetic wound healing by increasing fibronectin through PKC signalling pathway.
    Yan W; Liu H; Deng X; Jin Y; Wang N; Chu J
    J Tissue Eng Regen Med; 2018 Mar; 12(3):e1461-e1473. PubMed ID: 28872257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topically applied connective tissue growth factor/CCN2 improves diabetic preclinical cutaneous wound healing: potential role for CTGF in human diabetic foot ulcer healing.
    Henshaw FR; Boughton P; Lo L; McLennan SV; Twigg SM
    J Diabetes Res; 2015; 2015():236238. PubMed ID: 25789327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-29b promotes skin wound healing and reduces excessive scar formation by inhibition of the TGF-β1/Smad/CTGF signaling pathway.
    Guo J; Lin Q; Shao Y; Rong L; Zhang D
    Can J Physiol Pharmacol; 2017 Apr; 95(4):437-442. PubMed ID: 28092445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediation of transforming growth factor-beta(1)-stimulated matrix contraction by fibroblasts: a role for connective tissue growth factor in contractile scarring.
    Daniels JT; Schultz GS; Blalock TD; Garrett Q; Grotendorst GR; Dean NM; Khaw PT
    Am J Pathol; 2003 Nov; 163(5):2043-52. PubMed ID: 14578203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Layer-by-Layer Thin Films for Co-Delivery of TGF-β siRNA and Epidermal Growth Factor to Improve Excisional Wound Healing.
    Mandapalli PK; Labala S; Jose A; Bhatnagar S; Janupally R; Sriram D; Venuganti VV
    AAPS PharmSciTech; 2017 Apr; 18(3):809-820. PubMed ID: 27350274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.